Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02669290 · ClinicalTrials.gov registry record · NA
Use of 3-D Blood Pool Scintigraphy to Guide Left Ventricular Pacing Lead Placement in Patients Requiring Cardiac Resynchronization Therapy
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02669290 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 60 participants.
The verdict
NCT02669290, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether multiple gated acquisition (MUGA) guided lead placement improves clinical outcomes for patients needing cardiac resynchronization therapy (CRT) compared to traditional posterolateral left ventricular lead placement.
Interventions
- OTHER Guided
- OTHER Non-guided
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-01 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02669290
The ClinicalTrials.gov registry entry for NCT02669290 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Guided is the first listed.
NCT02669290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02669290 about?
NCT02669290 is a clinical study titled "Use of 3-D Blood Pool Scintigraphy to Guide Left Ventricular Pacing Lead Placement in Patients Requiring Cardiac Resynchronization Therapy". The purpose of this study is to determine whether multiple gated acquisition (MUGA) guided lead placement improves clinical outcomes for patients needing cardiac resynchronization therapy (CRT) compared to traditional posterolateral left ventricular lead placement.
What is the current status of trial NCT02669290?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2007-01. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02669290?
The interventions under investigation include: Guided (OTHER), Non-guided (OTHER).
Who is sponsoring clinical trial NCT02669290?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.